Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+819K
-
Total reported value, excl. options
-
$540M
-
Value change
-
+$2.12M
-
Put/Call ratio
-
0.76
-
Number of buys
-
63
-
Number of sells
-
-46
-
Price
-
$4.59
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2021
137 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2021.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 363M outstanding shares and own 32.41% of the company stock.
Largest 10 shareholders include Artal Group S.A. (71.2M shares), BVF INC/IL (8.39M shares), FMR LLC (7.44M shares), BlackRock Inc. (4.65M shares), VANGUARD GROUP INC (3.97M shares), D. E. Shaw & Co., Inc. (3.4M shares), NEA Management Company, LLC (2.38M shares), PINNACLE ASSOCIATES LTD (2.19M shares), JPMORGAN CHASE & CO (1.31M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.28M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.